These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24549732)

  • 1. Investigations into the fouling mechanism of parvovirus filters during filtration of freeze-thawed mAb drug substance solutions.
    Barnard JG; Kahn D; Cetlin D; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Mar; 103(3):890-9. PubMed ID: 24549732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
    De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
    PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
    Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
    PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.
    Barnard JG; Singh S; Randolph TW; Carpenter JF
    J Pharm Sci; 2011 Feb; 100(2):492-503. PubMed ID: 20803602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
    Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
    J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.
    Hauptmann A; Podgoršek K; Kuzman D; Srčič S; Hoelzl G; Loerting T
    Pharm Res; 2018 Mar; 35(5):101. PubMed ID: 29556730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fouling Behavior during Sterile Filtration of Different Glycoconjugate Serotypes Used in Conjugate Vaccines.
    Emami P; Fallahianbijan F; Dinse E; Motevalian SP; Conde BC; Reilly K; Zydney AL
    Pharm Res; 2021 Jan; 38(1):155-163. PubMed ID: 33438097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration.
    Maerz H; Hahn SO; Maassen A; Meisel H; Roggenbuck D; Sato T; Tanzmann H; Emmrich F; Marx U
    Nat Biotechnol; 1996 May; 14(5):651-2. PubMed ID: 9630961
    [No Abstract]   [Full Text] [Related]  

  • 10. Opalescence in monoclonal antibody solutions and its correlation with intermolecular interactions in dilute and concentrated solutions.
    Raut AS; Kalonia DS
    J Pharm Sci; 2015 Apr; 104(4):1263-74. PubMed ID: 25556561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on fouling mechanisms for recombinant human growth hormone sterile filtration.
    Maa YF; Hsu CC
    J Pharm Sci; 1998 Jul; 87(7):808-12. PubMed ID: 9649347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particles shed from syringe filters and their effects on agitation-induced protein aggregation.
    Liu L; Randolph TW; Carpenter JF
    J Pharm Sci; 2012 Aug; 101(8):2952-9. PubMed ID: 22674153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelation of a monoclonal antibody at the silicone oil-water interface and subsequent rupture of the interfacial gel results in aggregation and particle formation.
    Mehta SB; Lewus R; Bee JS; Randolph TW; Carpenter JF
    J Pharm Sci; 2015 Apr; 104(4):1282-90. PubMed ID: 25639229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of virus preparation quality on parvovirus filter performance.
    Slocum A; Burnham M; Genest P; Venkiteshwaran A; Chen D; Hughes J
    Biotechnol Bioeng; 2013 Jan; 110(1):229-39. PubMed ID: 22766979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving viral filtration capacity in biomanufacturing processes using aggregate binding properties of polyamide-6,6.
    Stanevich V; Pachalla A; Nunez B; McInnes M; Nieder C; Schreffler J
    Biotechnol Bioeng; 2021 Mar; 118(3):1105-1115. PubMed ID: 33241852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.
    Pardeshi NN; Zhou C; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of active amphotericin B after filtration through membrane filters.
    Tripple M; Shadomy S; Espinel-Ingroff A
    Am Rev Respir Dis; 1977 May; 115(5):879-81. PubMed ID: 857722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing.
    Kueltzo LA; Wang W; Randolph TW; Carpenter JF
    J Pharm Sci; 2008 May; 97(5):1801-12. PubMed ID: 17823949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the capacity of parvovirus-retentive membranes: performance of the Viresolve Prefilter.
    Bolton GR; Spector S; Lacasse D
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):55-63. PubMed ID: 16207176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.